Needelman Asset Management Inc. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,057 shares of the healthcare conglomerate’s stock after selling 348 shares during the quarter. UnitedHealth Group comprises approximately 4.3% of Needelman Asset Management Inc.’s portfolio, making the stock its 2nd biggest holding. Needelman Asset Management Inc.’s holdings in UnitedHealth Group were worth $1,679,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Jackson Grant Investment Advisers Inc. lifted its position in UnitedHealth Group by 0.4% during the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares during the period. Parkside Financial Bank & Trust lifted its position in UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. Harwood Advisory Group LLC lifted its position in UnitedHealth Group by 0.8% during the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 15 shares during the period. Budros Ruhlin & Roe Inc. lifted its position in UnitedHealth Group by 0.8% during the first quarter. Budros Ruhlin & Roe Inc. now owns 1,832 shares of the healthcare conglomerate’s stock worth $301,000 after buying an additional 15 shares during the period. Finally, Hanson McClain Inc. lifted its position in UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after buying an additional 15 shares during the period. Hedge funds and other institutional investors own 86.21% of the company’s stock.

In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 25,600 shares of company stock worth $4,962,694 over the last quarter. 0.89% of the stock is currently owned by corporate insiders.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.23% during midday trading on Friday, reaching $198.18. The company’s stock had a trading volume of 4,198,691 shares. The stock’s 50-day moving average is $195.28 and its 200 day moving average is $180.64. UnitedHealth Group Incorporated has a 12 month low of $133.03 and a 12 month high of $200.76. The stock has a market capitalization of $191.61 billion, a P/E ratio of 23.81 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.96 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. UnitedHealth Group’s payout ratio is presently 35.13%.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/09/16/unitedhealth-group-incorporated-unh-position-trimmed-by-needelman-asset-management-inc.html.

Several equities analysts recently weighed in on UNH shares. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 target price on shares of UnitedHealth Group in a research report on Friday, July 21st. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 target price on the stock in a research report on Tuesday, May 30th. Jefferies Group LLC reiterated a “buy” rating and set a $192.00 target price on shares of UnitedHealth Group in a research report on Friday, May 19th. Finally, Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $203.41.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.